These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 16706551)

  • 1. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.
    Pence BW; Miller WC; Gaynes BN; Eron JJ
    J Acquir Immune Defic Syndr; 2007 Feb; 44(2):159-66. PubMed ID: 17146374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.
    Tegger MK; Crane HM; Tapia KA; Uldall KK; Holte SE; Kitahata MM
    AIDS Patient Care STDS; 2008 Mar; 22(3):233-43. PubMed ID: 18290749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple diagnosis: dual diagnosis and HIV disease, Part 1.
    Douaihy AB; Jou RJ; Gorske T; Salloum IM
    AIDS Read; 2003 Jul; 13(7):331-2, 339-41. PubMed ID: 12889451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.
    Mellins CA; Havens JF; McDonnell C; Lichtenstein C; Uldall K; Chesney M; Santamaria EK; Bell J
    AIDS Care; 2009 Feb; 21(2):168-77. PubMed ID: 19229685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
    HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa.
    Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska J
    AIDS Behav; 2012 Aug; 16(6):1464-71. PubMed ID: 22001934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use.
    Chander G; Himelhoch S; Fleishman JA; Hellinger J; Gaist P; Moore RD; Gebo KA
    AIDS Care; 2009 May; 21(5):655-63. PubMed ID: 19444675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of illicit drug use and substance abuse treatment on adherence to HAART.
    Hicks PL; Mulvey KP; Chander G; Fleishman JA; Josephs JS; Korthuis PT; Hellinger J; Gaist P; Gebo KA;
    AIDS Care; 2007 Oct; 19(9):1134-40. PubMed ID: 18058397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.
    Arnsten JH; Demas PA; Grant RW; Gourevitch MN; Farzadegan H; Howard AA; Schoenbaum EE
    J Gen Intern Med; 2002 May; 17(5):377-81. PubMed ID: 12047736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief mental health and substance abuse screener for persons with HIV.
    Whetten K; Reif S; Swartz M; Stevens R; Ostermann J; Hanisch L; Eron JJ
    AIDS Patient Care STDS; 2005 Feb; 19(2):89-99. PubMed ID: 15716640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection.
    Tucker JS; Burnam MA; Sherbourne CD; Kung FY; Gifford AL
    Am J Med; 2003 May; 114(7):573-80. PubMed ID: 12753881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons.
    Turner BJ; Fleishman JA; Wenger N; London AS; Burnam MA; Shapiro MF; Bing EG; Stein MD; Longshore D; Bozzette SA
    J Gen Intern Med; 2001 Sep; 16(9):625-33. PubMed ID: 11556944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
    Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
    Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
    Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L
    Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance abuse and symptoms of mental illness among HIV-positive persons in the Southeast.
    Whetten K; Reif SS; Napravnik S; Swartz MS; Thielman NM; Eron JJ; Lowe K; Soto T
    South Med J; 2005 Jan; 98(1):9-14. PubMed ID: 15678633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: a review of the literature.
    Uldall KK; Palmer NB; Whetten K; Mellins C;
    AIDS Care; 2004; 16 Suppl 1():S71-96. PubMed ID: 15736823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual diagnosis vs. triple diagnosis in HIV: a comparative study to evaluate the differences in psychopathology and suicidal risk in HIV positive male subjects.
    Gupta M; Kumar K; Garg PD
    Asian J Psychiatr; 2013 Dec; 6(6):515-20. PubMed ID: 24309864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responding to the threat of HIV among persons with mental illness and substance abuse.
    Parry CD; Blank MB; Pithey AL
    Curr Opin Psychiatry; 2007 May; 20(3):235-41. PubMed ID: 17415075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.